The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Epoetin (Eritropoyetin) Market Research Report 2024
Synopsis
Epoetin can be given intravenously or, more conveniently, subcutaneously, when a 25–50% lower dose can be used.
The global Epoetin (Eritropoyetin) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Epoetin (Eritropoyetin) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Epoetin (Eritropoyetin) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Epoetin (Eritropoyetin) include Amgen, Epoetin, Abcam, Johnson & Johnson, Hospira Inc, Roche, LG Life Sciences Ltd, Biocon and Intas Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epoetin (Eritropoyetin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin (Eritropoyetin).
Report Scope
The Epoetin (Eritropoyetin) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epoetin (Eritropoyetin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epoetin (Eritropoyetin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Epoetin
Abcam
Johnson & Johnson
Hospira Inc
Roche
LG Life Sciences Ltd
Biocon
Intas Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Ranbaxy Laboratories Ltd
Celltrion, Inc
Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin Alfa
Segment by Application
Anemia (Cancer and HIV Treatment)
Kidney Disorders (ESRD and Dialysis)
Others (Neural Disease and Wound Healing)
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epoetin (Eritropoyetin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epoetin (Eritropoyetin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Epoetin can be given intravenously or, more conveniently, subcutaneously, when a 25–50% lower dose can be used.
The global Epoetin (Eritropoyetin) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Epoetin (Eritropoyetin) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Epoetin (Eritropoyetin) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Epoetin (Eritropoyetin) include Amgen, Epoetin, Abcam, Johnson & Johnson, Hospira Inc, Roche, LG Life Sciences Ltd, Biocon and Intas Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epoetin (Eritropoyetin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin (Eritropoyetin).
Report Scope
The Epoetin (Eritropoyetin) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epoetin (Eritropoyetin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epoetin (Eritropoyetin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Epoetin
Abcam
Johnson & Johnson
Hospira Inc
Roche
LG Life Sciences Ltd
Biocon
Intas Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Ranbaxy Laboratories Ltd
Celltrion, Inc
Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin Alfa
Segment by Application
Anemia (Cancer and HIV Treatment)
Kidney Disorders (ESRD and Dialysis)
Others (Neural Disease and Wound Healing)
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epoetin (Eritropoyetin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epoetin (Eritropoyetin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Epoetin (Eritropoyetin) Market Overview
1.1 Product Overview and Scope of Epoetin (Eritropoyetin)
1.2 Epoetin (Eritropoyetin) Segment by Type
1.2.1 Global Epoetin (Eritropoyetin) Market Value Comparison by Type (2024-2030)
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin Alfa
1.3 Epoetin (Eritropoyetin) Segment by Application
1.3.1 Global Epoetin (Eritropoyetin) Market Value by Application: (2024-2030)
1.3.2 Anemia (Cancer and HIV Treatment)
1.3.3 Kidney Disorders (ESRD and Dialysis)
1.3.4 Others (Neural Disease and Wound Healing)
1.4 Global Epoetin (Eritropoyetin) Market Size Estimates and Forecasts
1.4.1 Global Epoetin (Eritropoyetin) Revenue 2019-2030
1.4.2 Global Epoetin (Eritropoyetin) Sales 2019-2030
1.4.3 Global Epoetin (Eritropoyetin) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Epoetin (Eritropoyetin) Market Competition by Manufacturers
2.1 Global Epoetin (Eritropoyetin) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Epoetin (Eritropoyetin) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Epoetin (Eritropoyetin) Average Price by Manufacturers (2019-2024)
2.4 Global Epoetin (Eritropoyetin) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Epoetin (Eritropoyetin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epoetin (Eritropoyetin), Product Type & Application
2.7 Epoetin (Eritropoyetin) Market Competitive Situation and Trends
2.7.1 Epoetin (Eritropoyetin) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epoetin (Eritropoyetin) Players Market Share by Revenue
2.7.3 Global Epoetin (Eritropoyetin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epoetin (Eritropoyetin) Retrospective Market Scenario by Region
3.1 Global Epoetin (Eritropoyetin) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Epoetin (Eritropoyetin) Global Epoetin (Eritropoyetin) Sales by Region: 2019-2030
3.2.1 Global Epoetin (Eritropoyetin) Sales by Region: 2019-2024
3.2.2 Global Epoetin (Eritropoyetin) Sales by Region: 2025-2030
3.3 Global Epoetin (Eritropoyetin) Global Epoetin (Eritropoyetin) Revenue by Region: 2019-2030
3.3.1 Global Epoetin (Eritropoyetin) Revenue by Region: 2019-2024
3.3.2 Global Epoetin (Eritropoyetin) Revenue by Region: 2025-2030
3.4 North America Epoetin (Eritropoyetin) Market Facts & Figures by Country
3.4.1 North America Epoetin (Eritropoyetin) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Epoetin (Eritropoyetin) Sales by Country (2019-2030)
3.4.3 North America Epoetin (Eritropoyetin) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Epoetin (Eritropoyetin) Market Facts & Figures by Country
3.5.1 Europe Epoetin (Eritropoyetin) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Epoetin (Eritropoyetin) Sales by Country (2019-2030)
3.5.3 Europe Epoetin (Eritropoyetin) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epoetin (Eritropoyetin) Market Facts & Figures by Country
3.6.1 Asia Pacific Epoetin (Eritropoyetin) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Epoetin (Eritropoyetin) Sales by Country (2019-2030)
3.6.3 Asia Pacific Epoetin (Eritropoyetin) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Epoetin (Eritropoyetin) Market Facts & Figures by Country
3.7.1 Latin America Epoetin (Eritropoyetin) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Epoetin (Eritropoyetin) Sales by Country (2019-2030)
3.7.3 Latin America Epoetin (Eritropoyetin) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epoetin (Eritropoyetin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Epoetin (Eritropoyetin) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Epoetin (Eritropoyetin) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Epoetin (Eritropoyetin) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Epoetin (Eritropoyetin) Sales by Type (2019-2030)
4.1.1 Global Epoetin (Eritropoyetin) Sales by Type (2019-2024)
4.1.2 Global Epoetin (Eritropoyetin) Sales by Type (2025-2030)
4.1.3 Global Epoetin (Eritropoyetin) Sales Market Share by Type (2019-2030)
4.2 Global Epoetin (Eritropoyetin) Revenue by Type (2019-2030)
4.2.1 Global Epoetin (Eritropoyetin) Revenue by Type (2019-2024)
4.2.2 Global Epoetin (Eritropoyetin) Revenue by Type (2025-2030)
4.2.3 Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2019-2030)
4.3 Global Epoetin (Eritropoyetin) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Epoetin (Eritropoyetin) Sales by Application (2019-2030)
5.1.1 Global Epoetin (Eritropoyetin) Sales by Application (2019-2024)
5.1.2 Global Epoetin (Eritropoyetin) Sales by Application (2025-2030)
5.1.3 Global Epoetin (Eritropoyetin) Sales Market Share by Application (2019-2030)
5.2 Global Epoetin (Eritropoyetin) Revenue by Application (2019-2030)
5.2.1 Global Epoetin (Eritropoyetin) Revenue by Application (2019-2024)
5.2.2 Global Epoetin (Eritropoyetin) Revenue by Application (2025-2030)
5.2.3 Global Epoetin (Eritropoyetin) Revenue Market Share by Application (2019-2030)
5.3 Global Epoetin (Eritropoyetin) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Epoetin (Eritropoyetin) Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Epoetin
6.2.1 Epoetin Corporation Information
6.2.2 Epoetin Description and Business Overview
6.2.3 Epoetin Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Epoetin Epoetin (Eritropoyetin) Product Portfolio
6.2.5 Epoetin Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Corporation Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abcam Epoetin (Eritropoyetin) Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Epoetin (Eritropoyetin) Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Hospira Inc
6.5.1 Hospira Inc Corporation Information
6.5.2 Hospira Inc Description and Business Overview
6.5.3 Hospira Inc Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hospira Inc Epoetin (Eritropoyetin) Product Portfolio
6.5.5 Hospira Inc Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Roche Epoetin (Eritropoyetin) Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 LG Life Sciences Ltd
6.6.1 LG Life Sciences Ltd Corporation Information
6.6.2 LG Life Sciences Ltd Description and Business Overview
6.6.3 LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Portfolio
6.7.5 LG Life Sciences Ltd Recent Developments/Updates
6.8 Biocon
6.8.1 Biocon Corporation Information
6.8.2 Biocon Description and Business Overview
6.8.3 Biocon Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biocon Epoetin (Eritropoyetin) Product Portfolio
6.8.5 Biocon Recent Developments/Updates
6.9 Intas Pharmaceuticals
6.9.1 Intas Pharmaceuticals Corporation Information
6.9.2 Intas Pharmaceuticals Description and Business Overview
6.9.3 Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Portfolio
6.9.5 Intas Pharmaceuticals Recent Developments/Updates
6.10 Teva Pharmaceutical Industries Ltd
6.10.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.10.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Portfolio
6.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.11 Ranbaxy Laboratories Ltd
6.11.1 Ranbaxy Laboratories Ltd Corporation Information
6.11.2 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Description and Business Overview
6.11.3 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Portfolio
6.11.5 Ranbaxy Laboratories Ltd Recent Developments/Updates
6.12 Celltrion, Inc
6.12.1 Celltrion, Inc Corporation Information
6.12.2 Celltrion, Inc Epoetin (Eritropoyetin) Description and Business Overview
6.12.3 Celltrion, Inc Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Celltrion, Inc Epoetin (Eritropoyetin) Product Portfolio
6.12.5 Celltrion, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epoetin (Eritropoyetin) Industry Chain Analysis
7.2 Epoetin (Eritropoyetin) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epoetin (Eritropoyetin) Production Mode & Process
7.4 Epoetin (Eritropoyetin) Sales and Marketing
7.4.1 Epoetin (Eritropoyetin) Sales Channels
7.4.2 Epoetin (Eritropoyetin) Distributors
7.5 Epoetin (Eritropoyetin) Customers
8 Epoetin (Eritropoyetin) Market Dynamics
8.1 Epoetin (Eritropoyetin) Industry Trends
8.2 Epoetin (Eritropoyetin) Market Drivers
8.3 Epoetin (Eritropoyetin) Market Challenges
8.4 Epoetin (Eritropoyetin) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
